Allogene Therapeutics to Participate in Citi Virtual Oncology Leadership Summit and TD Cowen Health Care Conference
Reuters
Feb 05
Allogene <a href="https://laohu8.com/S/LENZ">Therapeutics</a> to Participate in Citi Virtual Oncology Leadership <a href="https://laohu8.com/S/SMMT">Summit</a> and TD Cowen Health Care Conference
Allogene Therapeutics Inc. will participate in Citi's 2026 Virtual Oncology Leadership Summit on February 18, 2026, at 9:15AM PT/12:15PM ET. The company will also attend the TD Cowen 46th Annual Health Care Conference on March 3, 2026, at 8:50AM PT/11:50AM ET. Webcasts of these events will be available on Allogene's website under the Investors tab in the News and Events section.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allogene Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9643942-en) on February 05, 2026, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.